rs876657405
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000331710.10(TBK1):βc.1436_1437delβ(p.Val479GlufsTer4) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000693 in 1,443,428 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0 ( 0 hom., cov: 32)
Exomes π: 6.9e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TBK1
ENST00000331710.10 frameshift
ENST00000331710.10 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
TBK1 (HGNC:11584): (TANK binding kinase 1) The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-64488579-CTG-C is Pathogenic according to our data. Variant chr12-64488579-CTG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 203436.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.1436_1437del | p.Val479GlufsTer4 | frameshift_variant | 12/21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.1436_1437del | p.Val479GlufsTer4 | frameshift_variant | 12/21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.1436_1437del | p.Val479GlufsTer4 | frameshift_variant | 12/21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.1535_1536del | non_coding_transcript_exon_variant | 12/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBK1 | ENST00000331710.10 | c.1436_1437del | p.Val479GlufsTer4 | frameshift_variant | 12/21 | 1 | NM_013254.4 | ENSP00000329967 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152138Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
152138
Hom.:
Cov.:
32
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.93e-7 AC: 1AN: 1443428Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 717280
GnomAD4 exome
AF:
AC:
1
AN:
1443428
Hom.:
AF XY:
AC XY:
0
AN XY:
717280
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74436
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2015 | - - |
Likely pathogenic, criteria provided, single submitter | research | Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University | Mar 31, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at